CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
Jennifer Jess(National Institutes of Health), Nirali N. Shah(National Institutes of Health), Terry J. Fry(University of Colorado Anschutz Medical Campus), Fiorella Schischlik(National Cancer Institute), Jon R. Inglefield(Frederick National Laboratory for Cancer Research), Daniel A. Lichtenstein(National Institutes of Health), Kevin R. Parker(Enable Biosciences (United States)), Bonnie Yates(National Institutes of Health), Jay N. Lozier(National Institutes of Health Clinical Center), Ansuman T. Satpathy(Palo Alto University), Shilpa Shahani(City of Hope), Haneen Shalabi(Center for Cancer Research), Eli Kane(National Institutes of Health), Martin Ongkeko(National Institutes of Health), Lauren Little(Rush University), Hannah Smith, Dong Chen(Mayo Clinic in Arizona), Hao‐Wei Wang(Fu Jen Catholic University), Alina Dulau‐Florea(National Institutes of Health), Yanyu Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ann Cullinane(National Institutes of Health)
Cited by 35
Related Papers
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k
Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion
|Nature Biotechnology|2019|1.1k
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
<i>Zbtb46</i> expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
|The Journal of Experimental Medicine|2012|608